Public Sector Pension Investment Board Has $84.68 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Public Sector Pension Investment Board grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.3% in the third quarter, Holdings Channel reports. The institutional investor owned 172,373 shares of the medical equipment provider’s stock after purchasing an additional 13,150 shares during the period. Public Sector Pension Investment Board’s holdings in Intuitive Surgical were worth $84,682,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in ISRG. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. LRI Investments LLC bought a new position in Intuitive Surgical in the first quarter worth $30,000. LGT Financial Advisors LLC boosted its stake in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the 3rd quarter valued at $33,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $538.55 on Thursday. The stock has a market capitalization of $191.82 billion, a P/E ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The company’s 50 day simple moving average is $507.94 and its 200-day simple moving average is $466.79. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the transaction, the general counsel now owns 1,595 shares in the company, valued at $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,459 shares of company stock worth $26,080,251 over the last 90 days. Insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ISRG. Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Raymond James upped their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $526.06.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.